Lysogene Announces Filing of 2021 Universal Registration Document
Regulatory News: Lysogene (Paris:LYS) (FR0013233475 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today announced the filing of its 2021 Universal
Source: finanznachrichten.de